Masataka Kuwana

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis

Shinji Sato, Michito Hirakata, Masataka Kuwana et al. · Arthritis & Rheumatism · 2005 · 742 citations

Life Sciences, Immunology, Pathology +17

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

Shinji Sato, Kana Hoshino, Takashi Satoh et al. · Arthritis & Rheumatism · 2009 · 600 citations

Life Sciences, Immunology, Pathology +17

Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

Dinesh Khanna, Daniel E. Furst, Philip J. Clements et al. · Journal of Scleroderma and Related Disorders · 2017 · 521 citations

Medicine, Clinical Sciences, Neurology +14